Company: INGN
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029993
Chunk: 71

Company: Inogen Inc
Filing Date: 2025-02-28
Form: 10-K
Item: Item 1B
Chunk 71
---
 page on our website which is located at http://investor.inogen.com. We will post any amendments to our code of business conduct and ethics, or waivers of its requirements, on our website.

ITEM 11. EXECUTIVE COMPENSATION

The information required by this item will be disclosed in the Proxy Statement and is incorporated herein by reference. 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDERS MATTERS

The information required by this item will be disclosed in the Proxy Statement and is incorporated herein by reference.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

The information required by this item will be disclosed in the Proxy Statement and is incorporated herein by reference.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

The information required by this item will be disclosed in the Proxy Statement and is incorporated herein by reference.

 78

PART IV 

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES 

(a)The following documents are filed as part of this Annual Report on Form 10-K: 

1.Financial Statements 

The consolidated financial statements listed in the accompanying index (page F-1) to the consolidated financial statements are filed as part of this Annual Report on Form 10-K. 

2.Financial Statement Schedules 

See Schedule II – Valuation and Qualifying Accounts and Reserves included herein. 

All other schedules have been omitted because the information either has been shown in the financial statements or notes thereto or is not applicable or required under this section. 

(b)Exhibits 

Exhibits are filed as part of this Annual Report on Form 10-K and are hereby incorporated by reference. Refer to Exhibit Index included herein.

ITEM 16. FORM 10-K SUMMARY

None. 

 79

Inogen, Inc. 

Index to Financial Statements 

and Financial Statement Schedule

    Report of Independent Registered Public Accounting Firm
     
    F-2

    Financial Statements

    Consolidated Balance Sheets as of December 31, 2024 and 2023
     
    F-4

    Consolidated Statements of Comprehensive Loss for the Years Ended December 31, 2024, 2023 and 2022
     
    F-5

    Consolidated Statements of Stockholders’ Equity for the Years Ended December 31, 2024, 2023 and